Back to Results

Nu Skin Enterprises Inc (NUS)

Nu Skin Enterprises, Inc. is a consumer staples company focused on beauty and wellness products. Through its subsidiaries, the company develops and distributes skin care, cosmetics, nutritional supplements, and related personal care items worldwide. Its product lineup includes devices and brands such as ageLOC LumiSpa, ageLOC LumiSpa iO, Nu Skin RenuSpa iO, ageLOC TruFace, Prysm iO, Nutricentials, Beauty Focus, ageLOC TRME, and LifePak. Nu Skin sells under the Nu Skin, Pharmanex, and ageLOC names through retail stores, websites, digital channels, independent direct sellers and marketers, and service centers. The company also conducts research and product development in skin care, nutritional supplements, and devices. Founded in 1984, Nu Skin is headquartered in Provo, Utah, and operates across Mainland China, South Korea, Southeast Asia/Pacific, the Americas, Japan, Hong Kong/Taiwan, and Europe & Africa.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-NUS
$6.91
52.5% Upside
Bargain
$12.77
181.9% Upside
Bargain
Fair
4.8%
0.4x
0.2x
220.5 M
317.2 M
56.6%
97.1%
4.1
-5.4%
-5.0%
Valuation • Fair Value

Nu Skin Enterprises Inc (NYSE-NUS) Fair Value by Valuation Model

Review the available estimates for Nu Skin Enterprises Inc (NYSE-NUS), including DDM Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$6.91

Estimated upside of 52.5% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DDM Fair Value

$4.18

Dividend discount model valuation reference.

Comps Fair Value

$7.37

Comparable-company valuation reference.

Analyst Price Target

$12.77

Analysts imply upside of 181.9%.

How to read these valuation models

Use the 5 available valuation references for Nu Skin Enterprises Inc (NYSE-NUS) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Nu Skin Enterprises Inc (NYSE-NUS)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.375 B

Current operating scale indicator.

Revenue Forecast

1.317 B

Forward revenue estimate.

EBITDA

120.3 M

Current operating profitability reference.

EBITDA Forecast

162.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Nu Skin Enterprises Inc (NYSE-NUS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Nu Skin Enterprises Inc (NYSE-NUS)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-3.97

No elevated caution signal from this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

-5.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Nu Skin Enterprises Inc (NYSE-NUS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Nu Skin Enterprises Inc (NYSE-NUS)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

4.8%

Current income yield reference.

Payout Ratio

-5.4%

Dividend payout reference.

How to read events and dividends

Review the currently available dividend data for Nu Skin Enterprises Inc (NYSE-NUS). No upcoming company event date is included in the latest data.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Nu Skin Enterprises Inc (NYSE-NUS) Stock FAQ

Data-supported answers about Nu Skin Enterprises Inc (NYSE-NUS), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$6.91
Estimated upside 52.5%
Valuation Rating
Undervalued
Estimated upside of 52.5%
Analyst Target
$12.77
Implied upside 181.9%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Nu Skin Enterprises Inc (NYSE-NUS) is $6.91. This implies an estimated upside of 52.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 52.5% versus the current market price.

The available analyst price target for Nu Skin Enterprises Inc (NYSE-NUS) is $12.77. The analyst target implies estimated upside of 181.9%.

The current financial health read for Nu Skin Enterprises Inc (NYSE-NUS) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 4.8%.

The current market capitalization listed for Nu Skin Enterprises Inc is 220.5 M.

The current enterprise value listed for Nu Skin Enterprises Inc is 317.2 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Nu Skin Enterprises Inc is NYSE-NUS, and the stock is listed on NYSE.

Nu Skin Enterprises Inc (NYSE-NUS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Nu Skin Enterprises Inc is 56.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Nu Skin Enterprises Inc is 97.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks View more on NYSE

Comparable companies from the same industry, limited to one security per issuer.

UL NYSE Unilever PLC ADR Fair Value Fair Market Cap 145.7 B
EL NYSE Estee Lauder Companies Inc Fair Value Fair Market Cap 39.005 B
ELF NYSE ELF Beauty Inc Fair Value Fair Market Cap 6.489 B
IPAR NASDAQ Inter Parfums Inc Fair Value Fair Market Cap 4.333 B
COTY NYSE Coty Inc Fair Value Undervalued Market Cap 3.443 B
HLF NYSE Herbalife Nutrition Ltd Fair Value Undervalued Market Cap 1.563 B
EPC NYSE Edgewell Personal Care Co Fair Value Undervalued Market Cap 1.316 B
BRBR NYSE Bellring Brands LLC Fair Value Bargain Market Cap 1.141 B
ODD NASDAQ Oddity Tech Ltd Fair Value Fair Market Cap 939.6 M
HNST NASDAQ Honest Company Inc Fair Value Overvalued Market Cap 476.3 M
USNA NYSE USANA Health Sciences Inc Fair Value Bargain Market Cap 256.1 M
NATR NASDAQ Natures Sunshine Products Inc Fair Value Bargain Market Cap 177.8 M
YSG NYSE Yatsen Holding Fair Value Bargain Market Cap 173.5 M
NAGE NASDAQ Niagen Bioscience Inc Fair Value Undervalued Market Cap 166.9 M
MED NYSE MEDIFAST INC Fair Value Undervalued Market Cap 132.5 M
FTLF NASDAQ FitLife Brands Inc Fair Value Undervalued Market Cap 75.129 M
SKIN NASDAQ Skinhealth Systems Inc Fair Value Undervalued Market Cap 67.348 M
LFVN NASDAQ Lifevantage Corporation Fair Value Undervalued Market Cap 63.764 M
UPXI NASDAQ Upexi Inc Fair Value Fair Market Cap 54.081 M
AXIL NYSE AXIL Brands Inc Fair Value Bargain Market Cap 35.41 M